News for Van Lanschot Kempen N.V. (VLK.AS)

The major U.S. index futures are currently pointing to a higher open on Monday, with stocks likely to extend the surge seen late in last Friday's session. The markets may benefit from an early upward move by shares of Tesla (TSLA), as the electric vehicle maker is jumping by 2.

**media[554951]**

**media[546147]**

**media[492781]**

Sep 05, 2024 / 06:30AM GMTPresentationSep 05, 2024 / 06:30AM GMT =====================Corporate Participants===================== * Sebastien Clerc Volt

Zealand Pharma completes registration of capital increase

Romij B.V. - Van Lanschot Kempen N.V. - 'S Hertogenbosch Romij B.V. - Van Lanschot Kempen N.V. - 'S Hertogenbosch Below you will find information from...

Van Lanschot Kempen N.V. Registration Document Van Lanschot Kempen N.V. Registration Document Below you will find information from the register...

Van Lanschot Kempen N.V. Van Lanschot Kempen N.V. Below you will find information from the register publication of inside information. The information...

NE PAS DIFFUSER DIRECTEMENT OU INDIRECTEMENT AUX ÉTATS-UNIS D'AMÉRIQUE, AU CANADA, EN AUSTRALIE ET AU JAPON. Communiqué de presse – Neuilly-sur-Seine,...

NE PAS DIFFUSER DIRECTEMENT OU INDIRECTEMENT AUX ÉTATS-UNIS D'AMÉRIQUE, AU CANADA, EN AUSTRALIE ET AU JAPON. Communiqué de presse –...

Van Lanschot Kempen N.V. Van Lanschot Kempen N.V. Below you will find information from the register publication of inside information. The information...

Van Lanschot Kempen N.V. Van Lanschot Kempen N.V. Below you will find information from the register publication of inside information. The information...

Convening notice 28 September 2023 Categories: Ad hoc announcement pursuant to article 53 LR, Information for shareholders ...

NAARDEN, The Netherlands and MIAMI, June 09, 2023 -- NewAmsterdam Pharma Company N.V. , a clinical-stage biopharmaceutical company developing oral, non-statin medicines for patients at high risk of... | June 9, 2023